Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc. operates comprehensively in the hemp-derived cannabidiol (CBD) wellness market, covering cultivation, manufacturing, marketing, and sales. The company's extensive product line features liquid hemp extract oil tinctures, a variety of gummies designed for benefits such as sleep, stress…
1D
-2.9%
1W
-11.8%
1M
-25.6%
6M
-59.6%
YTD
-32.3%
1Y
+34.0%
2Y
+91.4%
5Y
-85.4%
10Y
–
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~12% stronger price swings than usual
0
STRONG BUY
1
BUY
2
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Hold
As of: 10/08/2022
P/E
-1.16
P/B
0.7
EV/EBITDA
-4.88
RETURN ON EQUITY
-7.2%
NET MARGIN
-38.0%
DEBT/EQUITY
0.23
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
69.4%
FLOAT SHARES
110,738,461
AVG. DAILY VOLUME (30D)
40,487
Charlotte's Web Holdings, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is William Morachnick, the company employs around 112 people.
The IPO was on 13/09/2018; the stock trades on TSX under the ticker CWEB.TO.
3 analysts rate the stock, the consensus is Hold (as of 10/08/2022).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 12% stronger than usual.
No, Charlotte's Web Holdings currently does not pay a dividend.
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess Charlotte's Web Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.